{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:58:45Z","timestamp":1791615525648,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Four large community-randomized trials examining universal testing and treatment (UTT) to reduce HIV transmission were conducted between 2012\u20132018 in Botswana, Kenya, Uganda, Zambia and South Africa. In 2014, the UNAIDS 90\u201390-90 targets were adopted as a useful metric to monitor coverage. We systematically review the approaches used by the trials to measure intervention delivery, and estimate coverage against the 90\u201390-90 targets. We aim to provide in-depth understanding of the background contexts and complexities that affect estimation of population-level coverage related to the 90\u201390-90 targets.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Estimates were based predominantly on \u201cprocess\u201d data obtained during delivery of the interventions which included a combination of home-based and community-based services. Cascade coverage data included routine electronic health records, self-reported data, survey data, and active ascertainment of HIV viral load measurements in the field.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The estimated total adult populations of trial intervention communities included in this study ranged from 4,290 (TasP) to 142,250 (Zambian PopART Arm-B). The estimated total numbers of PLHIV ranged from 1,283 (TasP) to 20,541 (Zambian PopART Arm-B). By the end of intervention delivery, the first-90 target (knowledge of HIV status among all PLHIV) was met by all the trials (89.2%-94.0%). Three of the four trials also achieved the second- and third-90 targets, and viral suppression in BCPP and SEARCH exceeded the UNAIDS target of 73%, while viral suppression in the Zambian PopART Arm-A and B communities was within a small margin (~\u20093%) of the target.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>All four UTT trials aimed to implement wide-scale testing and treatment for HIV prevention at population level and showed substantial increases in testing and treatment for HIV in the intervention communities. This study has not uncovered any one estimation approach which is superior, rather that several approaches are available and researchers or policy makers seeking to measure coverage should reflect on background contexts and complexities that affect estimation of population-level coverage in their specific settings.<\/jats:p>\n                <jats:p>All four trials surpassed UNAIDS targets for universal testing in their intervention communities ahead of the 2020 milestone. All but one of the trials also achieved the 90\u201390 targets for treatment and viral suppression. UTT is a realistic option to achieve 95\u201395-95 by 2030 and fast-track the end of the HIV epidemic.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-14713-5","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T07:02:59Z","timestamp":1670914979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Achieving the UNAIDS 90\u201390-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa"],"prefix":"10.1186","volume":"22","author":[{"given":"K.","family":"Sabapathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Balzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Larmarange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Iwuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ayles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kamya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Havlir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"14713_CR1","volume-title":"90\u201390\u201390: An ambitious treatment target to help end the AIDS epidemic","author":"UNAIDS","year":"2014","unstructured":"UNAIDS. 90\u201390\u201390: An ambitious treatment target to help end the AIDS epidemic. 2014. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/90-90-90_en_0pdf.\u00a0Accessed on 11 Jan 2016."},{"key":"14713_CR2","volume-title":"World AIDS Day Report","author":"UNAIDS","year":"2020","unstructured":"UNAIDS. World AIDS Day Report. 2020. https:\/\/www.unaids.org\/en\/resources\/documents\/2020\/2020-World-AIDS-Day-report-graphs-tables.\u00a0Accessed 28 Jan 2021."},{"key":"14713_CR3","volume-title":"Fast-track: ending the AIDS epidemic by 2030","author":"UNAIDS","year":"2015","unstructured":"UNAIDS. Fast-track: ending the AIDS epidemic by 2030. 2015. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC2686_WAD2014report_enpdf.\u00a0Accessed on 11 Jan 2016."},{"issue":"9657","key":"14713_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","volume":"373","author":"RM Granich","year":"2009","unstructured":"Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48\u201357.","journal-title":"Lancet"},{"key":"14713_CR5","volume-title":"Botswana Combination Prevention Project (BCPP)","author":"BCPP Study Group","year":"2013","unstructured":"BCPP Study Group. Botswana Combination Prevention Project (BCPP). 2013. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01965470.\u00a0Accessed on 19 Oct 2016."},{"key":"14713_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1745-6215-14-230","volume":"14","author":"CC Iwuji","year":"2013","unstructured":"Iwuji CC, Orne-Gliemann J, Tanser F, Boyer S, Lessells RJ, Lert F, et al. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials. 2013;14:230.","journal-title":"Trials"},{"key":"14713_CR7","volume-title":"Sustainable East Africa Research in Community Health (SEARCH)","author":"SEARCH Study Team","year":"2013","unstructured":"SEARCH Study Team. Sustainable East Africa Research in Community Health (SEARCH). 2013. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01864603?term=NCT01864603&rank=1.\u00a0Accessed on 26 Nov 2015."},{"key":"14713_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1745-6215-15-57","volume":"15","author":"R Hayes","year":"2014","unstructured":"Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial. Trials. 2014;15:57.","journal-title":"Trials"},{"issue":"1","key":"14713_CR9","doi-asserted-by":"publisher","first-page":"e25048","DOI":"10.1002\/jia2.25048","volume":"21","author":"D Perriat","year":"2018","unstructured":"Perriat D, Balzer L, Hayes R, Lockman S, Walsh F, Ayles H, et al. Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa. J Int AIDS Soc. 2018;21(1):e25048.","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"14713_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1056\/NEJMoa1809866","volume":"381","author":"DV Havlir","year":"2019","unstructured":"Havlir DV, Balzer LB, Charlebois ED, Clark TD, Kwarisiima D, Ayieko J, et al. HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa. N Engl J Med. 2019;381(3):219\u201329.","journal-title":"N Engl J Med"},{"issue":"3","key":"14713_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1814556","volume":"381","author":"RJ Hayes","year":"2019","unstructured":"Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, et al. Effect of universal testing and treatment on HIV incidence - HPTN 071 (PopART). N Engl J Med. 2019;381(3):207\u201318.","journal-title":"N Engl J Med"},{"issue":"3","key":"14713_CR12","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/S2352-3018(17)30205-9","volume":"5","author":"CC Iwuji","year":"2018","unstructured":"Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F, et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV. 2018;5(3):e116\u201325.","journal-title":"Lancet HIV"},{"issue":"3","key":"14713_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1812281","volume":"381","author":"J Makhema","year":"2019","unstructured":"Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, et al. Universal testing, expanded treatment, and incidence of HIV infection in Botswana. N Engl J Med. 2019;381(3):230\u201342.","journal-title":"N Engl J Med"},{"issue":"8","key":"14713_CR14","doi-asserted-by":"publisher","first-page":"e0255227","DOI":"10.1371\/journal.pone.0255227","volume":"16","author":"R Lebelonyane","year":"2021","unstructured":"Lebelonyane R, Bachanas P, Block L, Ussery F, Alwano MG, Marukutira T, et al. To achieve 95\u201395-95 targets we must reach men and youth: high level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach. PLoS One. 2021;16(8):e0255227.","journal-title":"PLoS One"},{"issue":"22","key":"14713_CR15","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1001\/jama.2009.828","volume":"301","author":"CW Dieffenbach","year":"2009","unstructured":"Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301(22):2380\u20132.","journal-title":"JAMA"},{"key":"14713_CR16","volume-title":"Statistical analysis plan for SEARCH phase I: health outcomes among adults","author":"L Balzer","year":"2018","unstructured":"Balzer L, Havlir D, Schwab J, van der Laan M, Petersen M. Statistical analysis plan for SEARCH phase I: health outcomes among adults. 2018. https:\/\/arxiv.org\/abs\/180803231.\u00a0Accessed 28 Jan 2021."},{"issue":"4","key":"14713_CR17","doi-asserted-by":"publisher","first-page":"e1003067","DOI":"10.1371\/journal.pmed.1003067","volume":"17","author":"S Floyd","year":"2020","unstructured":"Floyd S, Shanaube K, Yang B, Schaap A, Griffith S, Phiri M, et al. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: an analysis of findings from the HPTN 071 (PopART) trial. PLoS Med. 2020;17(4):e1003067.","journal-title":"PLoS Med"},{"issue":"6","key":"14713_CR18","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/S2352-3018(20)30103-X","volume":"7","author":"KE Wirth","year":"2020","unstructured":"Wirth KE, Gaolathe T, Pretorius Holme M, Mmalane M, Kadima E, Chakalisa U, et al. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie\/BCPP): a cluster-randomised trial. Lancet HIV. 2020;7(6):e422\u201333.","journal-title":"Lancet HIV"},{"issue":"7","key":"14713_CR19","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"5","key":"14713_CR20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/EDE.0000000000001215","volume":"31","author":"LB Balzer","year":"2020","unstructured":"Balzer LB, Ayieko J, Kwarisiima D, Chamie G, Charlebois ED, Schwab J, et al. Far from MCAR: obtaining population-level estimates of HIV viral suppression. Epidemiology. 2020;31(5):620\u20137.","journal-title":"Epidemiology"},{"issue":"10092","key":"14713_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(17)31872-X","volume":"390","author":"R Granich","year":"2017","unstructured":"Granich R, Williams B, Montaner J, Zuniga JM. 90\u201390-90 and ending AIDS: necessary and feasible. Lancet. 2017;390(10092):341\u20133.","journal-title":"Lancet"},{"issue":"2","key":"14713_CR22","first-page":"83","volume":"20","author":"H Joulaei","year":"2018","unstructured":"Joulaei H, Shooshtarian S, Dianatinasab M. Is UNAIDS 90\u201390-90 target a dream or a reality for Middle East and North Africa Region on ending the AIDS Epidemic? A review study. AIDS Rev. 2018;20(2):83\u201393.","journal-title":"AIDS Rev"},{"issue":"Suppl 4","key":"14713_CR23","doi-asserted-by":"publisher","first-page":"e25128","DOI":"10.1002\/jia2.25128","volume":"21","author":"J Larmarange","year":"2018","unstructured":"Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiebaut R, et al. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 treatment as prevention trial in rural KwaZulu-Natal (South Africa). J Int AIDS Soc. 2018;21(Suppl 4):e25128.","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"14713_CR24","doi-asserted-by":"publisher","first-page":"e0239513","DOI":"10.1371\/journal.pone.0239513","volume":"15","author":"C Iwuji","year":"2020","unstructured":"Iwuji C, Chimukuche RS, Zuma T, Plazy M, Larmarange J, Orne-Gliemann J, et al. Test but not treat: Community members\u2019 experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa. PLoS ONE. 2020;15(9):e0239513.","journal-title":"PLoS ONE"},{"issue":"4","key":"14713_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/QAI.0000000000001938","volume":"80","author":"A Gosset","year":"2019","unstructured":"Gosset A, Protopopescu C, Larmarange J, Orne-Gliemann J, McGrath N, Pillay D, et al. Retention in care trajectories of HIV-positive individuals participating in a universal test-and-treat program in rural South Africa (ANRS 12249 TasP Trial). J Acquir Immune Defic Syndr. 2019;80(4):375\u201385.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"21","key":"14713_CR26","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1001\/jama.2017.5705","volume":"317","author":"M Petersen","year":"2017","unstructured":"Petersen M, Balzer L, Kwarsiima D, Sang N, Chamie G, Ayieko J, et al. Association of Implementation of a universal testing and treatment intervention with HIV diagnosis, receipt of antiretroviral therapy, and viral suppression in East Africa. JAMA. 2017;317(21):2196\u2013206.","journal-title":"JAMA"},{"issue":"8","key":"14713_CR27","doi-asserted-by":"publisher","first-page":"e1002107","DOI":"10.1371\/journal.pmed.1002107","volume":"13","author":"CC Iwuji","year":"2016","unstructured":"Iwuji CC, Orne-Gliemann J, Larmarange J, Okesola N, Tanser F, Thiebaut R, et al. Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in Rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS 12249 TasP Cluster-Randomised Trial. PLoS Med. 2016;13(8):e1002107.","journal-title":"PLoS Med"},{"issue":"1","key":"14713_CR28","doi-asserted-by":"publisher","first-page":"20913","DOI":"10.7448\/IAS.19.1.20913","volume":"19","author":"M Plazy","year":"2016","unstructured":"Plazy M, Farouki KE, Iwuji C, Okesola N, Orne-Gliemann J, Larmarange J, et al. Access to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster-randomized trial in rural South Africa. J Int AIDS Soc. 2016;19(1):20913.","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"14713_CR29","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/QAD.0000000000002502","volume":"34","author":"NA Haber","year":"2020","unstructured":"Haber NA, Lesko CR, Fox MP, Powers KA, Harling G, Edwards JK, et al. Limitations of the UNAIDS 90\u201390-90 metrics: a simulation-based comparison of cross-sectional and longitudinal metrics for the HIV care continuum. AIDS. 2020;34(7):1047\u201355.","journal-title":"AIDS"},{"issue":"10","key":"14713_CR30","doi-asserted-by":"publisher","first-page":"e25402","DOI":"10.1002\/jia2.25402","volume":"22","author":"J Larmarange","year":"2019","unstructured":"Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiebaut R, et al. Temporal trends of population viral suppression in the context of universal test and treat: the ANRS 12249 TasP trial in rural South Africa. J Int AIDS Soc. 2019;22(10):e25402.","journal-title":"J Int AIDS Soc"},{"key":"14713_CR31","doi-asserted-by":"publisher","unstructured":"Barnabas RV, van Rooyen H, Tumwesigye E, Brantley J, Baeten JM, van Heerden A, et al. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda. Lancet HIV. 2016;3(5):e212\u201320. https:\/\/doi.org\/10.1016\/S2352-3018(16)00020-5.","DOI":"10.1016\/S2352-3018(16)00020-5"},{"key":"14713_CR32","doi-asserted-by":"publisher","unstructured":"Sabapathy K, Hayes R. Linkage to care: a step on the path, but not the destination. Lancet HIV. 2016;3(5):e193\u20134. https:\/\/doi.org\/10.1016\/S2352-3018(16)00038-2.","DOI":"10.1016\/S2352-3018(16)00038-2"},{"issue":"7","key":"14713_CR33","doi-asserted-by":"publisher","first-page":"e0200737","DOI":"10.1371\/journal.pone.0200737","volume":"13","author":"K Sabapathy","year":"2018","unstructured":"Sabapathy K, Hensen B, Varsaneux O, Floyd S, Fidler S, Hayes R. The cascade of care following community-based detection of HIV in sub-Saharan Africa - a systematic review with 90\u201390-90 targets in sight. PLoS ONE. 2018;13(7):e0200737.","journal-title":"PLoS ONE"},{"issue":"Suppl 3","key":"14713_CR34","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1097\/QAD.0000000000002355","volume":"33","author":"K Marsh","year":"2019","unstructured":"Marsh K, Eaton JW, Mahy M, Sabin K, Autenrieth CS, Wanyeki I, et al. Global, regional and country-level 90\u201390-90 estimates for 2018: assessing progress towards the 2020 target. AIDS. 2019;33(Suppl 3):S213\u201326.","journal-title":"AIDS"},{"issue":"4","key":"14713_CR35","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10461-019-02408-9","volume":"23","author":"A Lasry","year":"2019","unstructured":"Lasry A, Bachanas P, Suraratdecha C, Alwano MG, Behel S, Pals S, et al. Cost of community-based HIV testing activities to reach saturation in Botswana. AIDS Behav. 2019;23(4):875\u201382.","journal-title":"AIDS Behav"},{"issue":"15","key":"14713_CR36","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1097\/QAD.0000000000001958","volume":"32","author":"SB Shade","year":"2018","unstructured":"Shade SB, Osmand T, Luo A, Aine R, Assurah E, Mwebaza B, et al. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys. AIDS. 2018;32(15):2179\u201388.","journal-title":"AIDS"},{"key":"14713_CR37","doi-asserted-by":"publisher","unstructured":"Thomas R, Probert WJM, Sauter R, Mwenge L, Singh S, Kanema S, et al. HPTN 071 (PopART) study team. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial. Lancet Glob Health. 2021;9(5):e668\u201380. https:\/\/doi.org\/10.1016\/S2214-109X(21)00034-6.","DOI":"10.1016\/S2214-109X(21)00034-6"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-14713-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-14713-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-14713-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T22:06:06Z","timestamp":1671228366000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-14713-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14713"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-14713-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this paper as we report on new analyses of previously published data aggregate data which was fully de-identified and anonymised.\u00a0All participants who partook in research activities in the trials included in this paper provided written informed consent. Community members who received health interventions provided verbal consent for inclusion of their data in anonymised form for analyses of aggregate data. All four trials were conducted in accordance with the principles of the Declaration of Helsinki, with oversight by data and safety monitoring boards. Ethics approval for the BCPP trial was provided by the Botswana Health Research and Development Committee and the institutional review board of the Centers for Disease Control and Prevention trial. Ethics approval for the PopART trial\u00a0was granted by ethics committees at the London School of Hygiene and Tropical Medicine, University of Zambia, and Stellenbosch University.\u00a0Ethics approval for the SEARCH trial was provided by the ethics committees at the University of California, San Francisco; the Kenya Medical Research Institute; and Makerere University School of Medicine in Uganda. Ethics approval for the TASP trial was provided by the Biomedical Research Ethics Committee (BFC 104\/11) at the University of KwaZulu-Natal and the Medicines Control Council of South Africa.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2333"}}